Deuterated psilocybin analog

氘代裸盖菇素类似物

Report date: 2026/03/11 20:02:12
NME

Base Information

Drug NameDeuterated psilocybin analog
Drug Alias NameDeupsilocindeuterated tryptamineCYB-003
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Deuterated drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsDepressive Disorder, MajorDepressive DisorderAnxiety +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesPoland +[8] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesCybin Inc
China Registration ClassN/A

Develop Information

Active CompaniesOsmind IncCybin Irl LtdThe Ohio State University +[4] 
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorDepressive DisorderAnxiety +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A